Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients

References

• Cusi K, Isaacs S, Barb D, et al. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022;28(5):528–562. doi:10.1016/j.eprac.2022.03.010
   PubMed Web of Science ®Google Scholar
• Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019;70(3):531–544. doi:10.1016/j.jhep.2018.10.033
   PubMed Web of Science ®Google Scholar
• Estes C, Anstee QM, Arias-Loste MT, et al. Modeling MASLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904. doi:10.1016/j.jhep.2018.05.036
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Tampi R, Priyadarshini M, Nader F. Burden of illness and economic model for patients with Non-Alcoholic Steatohepatitis (NASH) in the United States. Hepatology. 2018;69(2). doi:10.1002/hep.30254
   Web of Science ®Google Scholar
• Fan XF, Deng YQ, Wu GL. [Study on the distribution and characteristics of Chinese medicine syndrome in patients with nonalcoholic fatty liver disease]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011;31(10):1332–1336. Chinese.
   PubMedGoogle Scholar
• Fierbinteanu Braticevici C, Sporea I, Panaitescu E, Tribus L. Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. Ultrasound Med Biol. 2013;39(11):1942–1950. doi:10.1016/j.ultrasmedbio.2013.04.019
   PubMed Web of Science ®Google Scholar
• Betancourt AM, King AL, Fetterman JL, et al. Mitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in mice. Biochem J. 2014;461(2):223–232. doi:10.1042/BJ20131433
   PubMedGoogle Scholar
• Zheng JS, Xu A, Huang T, Yu X, Li D. Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China. Lipids. 2012;47(6):549–556. doi:10.1007/s11745-012-3671-4
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference [published correction appears in Hepatology. 2003 Aug;38(2):536]. Hepatology. 2003;37(5):1202–1219. doi:10.1053/jhep.2003.50193
   PubMed Web of Science ®Google Scholar
• Elliott C, Frith J, Day CP, Jones DE, Newton JL. Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up. Dig Dis Sci. 2013;58(8):2383–2391. doi:10.1007/s10620-013-2657-2
   PubMed Web of Science ®Google Scholar
• Masuda K, Ono M, Fukumoto M, et al. Usefulness of Technetium-99 m-2-methoxy-isobutyl-isonitrile liver scintigraphy for evaluating disease activity of non-alcoholic fatty liver disease. Hepatol Res. 2012;42(3):273–279. doi:10.1111/j.1872-034X.2011.00923.x
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med. 2009;9(3):299–314. doi:10.2174/156652409787847191
   PubMed Web of Science ®Google Scholar
• Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (MASLD). Metabolism. 2016;65(8):1038–1048. doi:10.1016/j.metabol.2015.12.012
   PubMed Web of Science ®Google Scholar
• Ahmed KS, Khan AA, Ahmed I, et al. Prevalence study to elucidate the transmission pathways of Helicobacter pylori at oral and gastroduodenal sites of a South Indian population. Singapore Med J. 2006;47(4):291–296.
   PubMedGoogle Scholar
• Mladenova I, Durazzo M. Transmission of Helicobacter pylori. Minerva Gastroenterol Dietol. 2018;64(3):251–254. doi:10.23736/S1121-421X.18.02480-7
   PubMed Web of Science ®Google Scholar
• Tsay FW. Hsu PHPinfection and extra-gastroduode-nal diseases. J Biomed Sci. 2018;25(1):65. doi:10.1186/s12929-018-0469-6
   PubMed Web of Science ®Google Scholar
• Liu WZ, Xie Y, Lu H, et al. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018;23(2):e12475. doi:10.1111/hel.12475
   PubMed Web of Science ®Google Scholar
• Wessler S, Krisch LM, Elmer DP, Aberger F. From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases. Cell Commun Signal. 2017;15(1):15. doi:10.1186/s12964-017-0171-4
   PubMed Web of Science ®Google Scholar
• Lv NH, Xie C. Review and prospect of Helicobacter pylori infection research in China. Chin J Digest. 2021;41(4):217–220.
   Google Scholar
• Hanafiah A, Lopes BS. Genetic diversity and virulence characteristics of Helicobacter pylori isolates in different human ethnic groups. Infect Genet Evol. 2020;78:104135. doi:10.1016/j.meegid.2019.104135
   PubMed Web of Science ®Google Scholar
• Li LN, Liu Y, Zhang HC, Wu T, Dai Y, Wang WH. Effect of Helicobacter pylori infection on inflammatory colorectal cancer induced by AOM/DSS in mice and its immune mechanism. Nat Med J China. 2020;100(34):2689–2695. doi:10.3760/cma.j.cn112137-20200112-00076
   Google Scholar
• Wang J, Dong F, Su H, et al. H. pylori is related to NAFLD but only in female: a cross-sectional study. Int J Med Sci. 2021;18(11):2303–2311. doi:10.7150/ijms.50748
   PubMed Web of Science ®Google Scholar
• Tarantino G, Crocetto F, Di Vito C, et al. Association of MASLD and insulin resistance with non metastatic bladder cancer patients: a cross-sectional retrospective study. J Clin Med. 2021;10(2):346. doi:10.3390/jcm10020346
   PubMed Web of Science ®Google Scholar
• Zhu BB, Zhou HK, Bai XF, Liu Y, Li WP. Research progress on the relationship between Hp infection and non-alcoholic fatty liver disease. Hainan Med J. 2017;28(11):1833–1835.
   Google Scholar
• Zhou BG, Yang HJ, Xu W, Wang K, Guo P, Ai YW. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systematic review and meta-analysis of observational studies. Helicobacter. 2019;24(3):e12576. doi:10.1111/hel.12576
   PubMed Web of Science ®Google Scholar
• Tang DM, Kumar S. The Association Between Helicobacter pylori infection and nonalcoholic fatty liver disease. Curr Gastroenterol Rep. 2017;19(2):5. doi:10.1007/s11894-017-0545-1
   PubMedGoogle Scholar
• Polyzos SA, Kountouras J, Papatheodorou A, et al. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism. 2013;62(1):121–126. doi:10.1016/j.metabol.2012.06.007
   PubMed Web of Science ®Google Scholar
• Fan JG, Wei L, Zhuang H. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. J Pract Hepatol. 2018;21(2):177–186.
   Google Scholar
• Abdel-Razik A, Mousa N, Shabana W, et al. Helicobacter pylori and non-alcoholic fatty liver disease: a new enigma? Helicobacter. 2018;23(6):e12537. doi:10.1111/hel.12537
   PubMed Web of Science ®Google Scholar
• Chen C, Zhang C, Wang X, et al. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. Eur J Gastroenterol Hepatol. 2020;32(7):857–866. doi:10.1097/MEG.0000000000001601
   PubMed Web of Science ®Google Scholar
• Wu QQ, Qin K, wang YJ. Central obesity is associated with helicobacter pylori infection: a large-scale cross-sectional retrospective study in West China. Int J Diabetes Dev Countries. 2019;40(2). doi:10.1007/s13410-019-00765-8
   Google Scholar
• Kebapcilar L, Bilgir O, Cetinkaya E, Akyol M, Bilgir F, Bozkaya G. The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels. Clinics. 2010;65(8):799–802. doi:10.1590/s1807-59322010000800010
   PubMed Web of Science ®Google Scholar
• Cheng DD, He C, Ai HH, Huang Y, Lu NH. The possible role of helicobacter pylori infection in non-alcoholic fatty liver disease. Front Microbiol. 2017;8:743. doi:10.3389/fmicb.2017.00743
   PubMed Web of Science ®Google Scholar
• Chen CX, Mao YS, Foster P, Zhu ZW, Du J, Guo CY. Possible association between Helicobacter pylori infection and nonalcoholic fatty liver disease. Appl Physiol Nutr Metab. 2017;42(3):295–301. doi:10.1139/apnm-2016-0499
   PubMed Web of Science ®Google Scholar
• Nagura H, Ohtani H, Sasano H, Matsumoto T. The immuno-inflammatory mechanism for tissue injury in inflammatory bowel disease and Helicobacter pylori-infected chronic active gastritis. Roles of the mucosal immune system. Digestion. 2001;63(Suppl 1):12–21. doi:10.1159/000051905
   PubMedGoogle Scholar
• Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci. 2014;15(5):8591–8638. doi:10.3390/ijms15058591
   PubMed Web of Science ®Google Scholar
• Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J Clin Endocrinol Metab. 2012;97(12):4717–4723. doi:10.1210/jc.2012-2414
   PubMed Web of Science ®Google Scholar
• Li M, Shen Z, Li YM. Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. World J Gastroenterol. 2013;19(41):7024–7031. doi:10.3748/wjg.v19.i41.7024
   PubMed Web of Science ®Google Scholar
• Boursier J, Mueller O, Barret M, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63(3):764–775. doi:10.1002/hep.28356
   PubMed Web of Science ®Google Scholar
• Včev A, Nakić D, Mrđen A, et al. Helicobacter pylori infection and coronary artery disease. Coll Antropol. 2007;31(3):757–760.
   PubMedGoogle Scholar
• Chai Y, Guo N, Yao HX, et al. Effect of Helicobacter pylori eradication therapy on lipid metabolism and insulin resistance in non-alcoholic fatty liver disease. Chin J Nosocomiol. 2021;31(9):1319–1323.
   Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414
   PubMed Web of Science ®Google Scholar
• Yang SX, Cai SL, Yang N, et al. Effect of Helicobacter pylori infection on glucose and lipid metabolism in patients with metabolic syndrome. Chin J Nosocomiol. 2021;31(20):3135–3138.
   Google Scholar
• Tang WZ, Wang ZL, Wang XJ, et al. Study on the impact of Helicobacter pylori infection on glucose metabolism in patients with chronic hepatitis B cirrhosis. Chin J Nosocomiol. 2019;29(24):3715–3718.
   Google Scholar
• Cox MJ, Turek EM, Hennessy C, et al. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients. PLoS One. 2017;12(2):e0170622. doi:10.1371/journal.pone.0170622
   PubMed Web of Science ®Google Scholar
• Zhao JM, Yan XX, Li GX, et al. Characteristics of clinical feature in the patients with chronic obstructive pulmonary disease with bronchiectasis. IntJRespir. 2018;38(19):1460–1464.
   Google Scholar
• Zhao W, Zhang ZP, Wang DY, et al. Study on the correlation between IL-18, hs-CRP, and TNF-α expression in patients with gastric cancer complicated by Helicobacter pylori infection. Chin J Nosocomiol. 2020;30(11):1651–1654.
   Google Scholar
• Davarpanah E, Jafarzadeh A, Nemati M, et al. Circulating concentration of interleukin-37 in Helicobacter pylori-infected patients with peptic ulcer: its association with IL-37 related gene polymorphisms and bacterial virulence factor CagA. Cytokine. 2020;126:154928. doi:10.1016/j.cyto.2019.154928
   PubMed Web of Science ®Google Scholar
• He YK, Huang XL, Zhang XY, et al. Effect of vitamin D adjuvant therapy on serum levels of TNF-α, IL-6, and CRP in patients with non-alcoholic fatty liver disease. Hainan Med J. 2017;28(9):1481–1483.
   Google Scholar
• Li X, Liu S, Luo J, et al. Helicobacter pylori induces IL-1β and IL-18 production in human monocytic cell line through activation of NLRP3 inflammasome via ROS signaling pathway. Pathog Dis. 2015;73(4):ftu024. doi:10.1093/femspd/ftu024
   PubMed Web of Science ®Google Scholar
• Liu Q, Meng X, Li Y, et al. Natural products for the prevention and management of Helicobacter pylori infection. Compr Rev Food Sci Food Saf. 2018;17(4):937–952. doi:10.1111/1541-4337.12355
   PubMed Web of Science ®Google Scholar
• Tarantino G, Balsano C, Santini SJ, et al. It is high time physicians thought of natural products for alleviating MASLD. is there sufficient evidence to use them? Int J Mol Sci. 2021;22(24):13424. doi:10.3390/ijms222413424
   PubMed Web of Science ®Google Scholar
• Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low grade inflammation. South Med J. 2010;103(3):190–196. doi:10.1097/SMJ.ob0113e3181cf373f
   PubMed Web of Science ®Google Scholar
• Coronado MT, Pozzi AO, Punchard MA, González P, Fantidis P. Inflammation as a modulator of the HDL cholesterol induced inteleukin-10 production by human circulating mononuclear cells. Atherosclerosis. 2009;202(1):183–184. doi:10.1016/j.atherosclerosis.2008.03.015
   PubMed Web of Science ®Google Scholar
• Scharnagl H, Kist M, Grawitz AB, Koenig W, Wieland H, März W. Effect of Helicobacter pylori eradication on high density lipoprotein cholesterol. Am J Cardiol. 2004;93(2):219–220. doi:10.1016/j.amjcard.2003.09.045
   PubMed Web of Science ®Google Scholar
• Kanbay M, Gür G, Yücel M, Yilmaz U, Boyacioğlu S. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci. 2005;50(7):1228–1231. doi:10.1007/s10620-005-2764-9
   PubMed Web of Science ®Google Scholar
• Elizalde JI, Piqué JM, Moreno V, et al. Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen. Aliment Pharmacol Ther. 2002;16(3):577–586. doi:10.1046/j.1365-2036.2002.01202.x
   PubMed Web of Science ®Google Scholar
• Zhang L, Gail MH, Wang YQ, et al. A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr. 2006;84(4):912–919. doi:10.1093/ajcn/84.4.912
   PubMed Web of Science ®Google Scholar
• Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ. 1997;315(7117):1199–1201. doi:10.1136/bmj.315.7117.1199
   PubMedGoogle Scholar